8. Neuraminidase inhibitors remain the preferred drugs for the treatment and prevention
of influenza. Pediatricians should attempt to promptly identify children suspected
of having influenza for rapid antiviral treatment, when indicated, to reduce morbidity
9. It is critical to ensure timely vaccination of children at increased risk of complications from influenza, including those younger than 5 years and their household contacts, and children with chronic underlying medical conditions (chronic cardiopulmonary disease, neurologic or neurodevelopmental disorders, immune suppression and metabolic disease). Otherwise healthy children also need to be vaccinated, as they too experience important morbidity and mortality from influenza. During the 2015-’16 influenza season, 49% of children hospitalized with influenza had no recorded underlying medical condition, and nearly 60% of the reported pediatric deaths occurred in children with no underlying conditions.
Copyright © 2016 American Academy of Pediatrics